Based on the Varex Imaging Corp stock forecast from 3 analysts, the average analyst target price for Varex Imaging Corp is USD 22.50 over the next 12 months. Varex Imaging Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Varex Imaging Corp is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Varex Imaging Corp’s stock price was USD 7.63. Varex Imaging Corp’s stock price has changed by +2.28% over the past week, -38.96% over the past month and -55.59% over the last year.
No recent analyst target price found for Varex Imaging Corp
No recent average analyst rating found for Varex Imaging Corp
Company Overview Varex Imaging Corp
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah. Read Less
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detecto...Read More
Frequently Asked Questions About Varex Imaging Corp (VREX) Stock
Based on ratings from 3 analysts Varex Imaging Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 3 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on VREX's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for VREX is USD 22.50 over the next 12 months. The maximum analyst target price is USD 30 while the minimum anlayst target price is USD 15.
VREX stock's Price/Earning ratio is 17.84.
Our analysis grades VREX stock's Price / Earning ratio at F. This means that VREX stock's Price/Earning ratio is above 49% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this VREX may be fairly valued for its sector
The last closing price of VREX's stock was USD 7.63.
The most recent market capitalization for VREX is USD 0.34B.
Based on targets from 3 analysts, the average taret price for VREX is projected at USD 22.50 over the next 12 months.
This means that VREX's stock price may go up by +194.89% over the next 12 months.
We can't find any ETFs which contains Varex Imaging Corp's stock.
As per our most recent records Varex Imaging Corp has 2,300 Employees.
Varex Imaging Corp's registered address is 1678 S. Pioneer Road, Salt Lake City, UT, United States, 84104.
You can get more information about it from Varex Imaging Corp's website at https://www.vareximaging.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Varex Imaging Corp (VREX) Stock
Based on ratings from 3 analysts Varex Imaging Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 3 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on VREX's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for VREX is USD 22.50 over the next 12 months. The maximum analyst target price is USD 30 while the minimum anlayst target price is USD 15.
VREX stock's Price/Earning ratio is 17.84.
Our analysis grades VREX stock's Price / Earning ratio at F. This means that VREX stock's Price/Earning ratio is above 49% of the stocks in the Medical Devices sector in the NSD exchange.
Based on this VREX may be fairly valued for its sector
The last closing price of VREX's stock was USD 7.63.
The most recent market capitalization for VREX is USD 0.34B.
Based on targets from 3 analysts, the average taret price for VREX is projected at USD 22.50 over the next 12 months.
This means that VREX's stock price may go up by +194.89% over the next 12 months.
We can't find any ETFs which contains Varex Imaging Corp's stock.
As per our most recent records Varex Imaging Corp has 2,300 Employees.
Varex Imaging Corp's registered address is 1678 S. Pioneer Road, Salt Lake City, UT, United States, 84104.
You can get more information about it from Varex Imaging Corp's website at https://www.vareximaging.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for VREX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
